Promoting Smoking Cessation in the Community Via QTW 2015
Launched by THE UNIVERSITY OF HONG KONG · Aug 31, 2015
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hong Kong residents aged 18 or above
- • Smoke at least 1 cigarette per day in the past 3 months
- • Able to communicate in Cantonese
- • Exhaled carbon monoxide (CO) 4 ppm or above, assessed by a validated CO smokerlyzer
- • Have Intention to quit
- Exclusion Criteria:
- • Smokers who have difficulties (either physical or cognitive condition) to communicate
- • Currently following other smoking cessation programs
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Trial Officials
Man Ping Kelvin Wang, PhD
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials